Concurrent Chemoradiotherapy Shows Long-Term Survival after Conversion from Locally Advanced to Resectable Hepatocellular Carcinoma

PURPOSE: For locally unresectable hepatocellular carcinoma (HCC) patients, concurrent chemoradiotherapy (CCRT) has been applied as a loco-regional treatment. After shrinkage of tumors in selected patients, surgical resection is performed. The aim of this study was to evaluate prognostic factors and...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ik Jae, Kim, Jun Won, Han, Kwang Hyub, Kim, Ja Kyung, Kim, Kyung Sik, Choi, Jin Sub, Park, Young Nyun, Seong, Jinsil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4205687/
https://www.ncbi.nlm.nih.gov/pubmed/25323884
http://dx.doi.org/10.3349/ymj.2014.55.6.1489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4205687/
https://www.ncbi.nlm.nih.gov/pubmed/25323884
http://dx.doi.org/10.3349/ymj.2014.55.6.1489

Ejemplares similares